Liu Yimei, Ju Minjie, Pan Simeng, He Hongyu, Luo Zhe, Gu Zhunyong
Department of Critical Care Medicine, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China. Corresponding author: Gu Zhunyong, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Aug;29(8):689-693. doi: 10.3760/cma.j.issn.2095-4352.2017.08.004.
To evaluate the prognostic value of blood lactate (Lac) level in sepsis patients with or without diabetes.
106 patients admitted to intensive care unit (ICU) of Zhongshan Hospital Affiliated to Fudan University from April 2015 to November 2016 were enrolled. The patients with age > 18 years and the length of hospital stay > 24 hours were included. Records including blood Lac, serum creatinine (SCr), white blood cell count (WBC), platelet count (PLT), sequential organ failure assessment (SOFA) on the first day of admission; minimum oxygen index (PaO/FiO) in 3 days after admission; mechanical ventilation, whether there was a history of diabetes, usage of biguanides, etiology control treatment, usage of continuous renal replacement therapy (CRRT) were collected. According to the level of blood Lac patients were divided into high Lac group (Lac > 2 mmol/L) and low Lac group (Lac ≤ 2 mmol/L); based on their diabetic history, sepsis patients were divided into the diabetes group and non-diabetes group. The survival curve of each group was analyzed by Kaplan-Meier regression analysis, and the factors influencing the prognosis were analyzed by multivariate Cox regression analysis.
There were 76 males and 30 females sepsis patients, with an average age of (68.1±14.7) years old. In the 51 patients of low Lac group, there were 7 patients who suffered from diabetes. While in the 55 patients of high Lac group, there were 12 patients who suffered from diabetes. Compared with low Lac group, high Lac group had a higher age, higher SOFA score, and a lower proportion of patients who had the treatment of etiology control (all P < 0.05). There was no significant difference of blood Lac in sepsis patients with diabetes and those without diabetes (mmol/L: 3.03±2.73 vs. 2.81±2.40, P > 0.05). Kaplan-Meier survival curve analysis showed that the 90-day survival rate in the high Lac group was significantly lower than that in the low Lac group (56.36% vs. 90.20%, χ = 0.697, P = 0.008). The high Lac group without diabetes had lower survival rate, and the 90-day survival rate was significantly lower than that of the low Lac group without diabetes (58.14% vs. 90.90%, χ = 7.152, P = 0.007); there was no significant difference in 90-day survival rate between the high Lac group and the low Lac group with diabetes (50.00% vs. 85.71%, χ = 0.012, P = 0.914). Multivariate Cox regression analysis showed that blood Lac was an independent risk factor for the prognosis of sepsis patients [odds ratio (OR) = 3.863, 95% confidence interval (95%CI) = 1.237-12.060, P = 0.020]. After stratification according to their diabetic history, the blood Lac was an independent risk factor for the prognosis of sepsis patients without diabetes (OR = 4.816, 95%CI = 1.407-15.824, P = 0.010), but the blood Lac had no effect on the prognosis of sepsis patients with diabetes (OR = 0.000, 95%CI = 0.000-1.103, P = 0.270).
The predictive value of blood Lac on sepsis patients with or without diabetes was different. The blood Lac was related with the prognosis of sepsis patients without diabetes, while further study should be conducted for the prognostic value of blood Lac in sepsis patients with diabetes, and it's possible to increase the cut-off-point of Lac level in these patients.
评估血乳酸(Lac)水平对合并或未合并糖尿病的脓毒症患者的预后价值。
选取2015年4月至2016年11月在复旦大学附属中山医院重症监护病房(ICU)收治的106例患者。纳入年龄>18岁且住院时间>24小时的患者。收集入院首日的血Lac、血清肌酐(SCr)、白细胞计数(WBC)、血小板计数(PLT)、序贯器官衰竭评估(SOFA);入院后3天内的最低氧合指数(PaO/FiO);机械通气情况、是否有糖尿病史、双胍类药物使用情况、病因控制治疗情况、连续性肾脏替代治疗(CRRT)使用情况。根据血Lac水平将患者分为高Lac组(Lac>2 mmol/L)和低Lac组(Lac≤2 mmol/L);根据糖尿病史将脓毒症患者分为糖尿病组和非糖尿病组。采用Kaplan-Meier回归分析每组的生存曲线,采用多因素Cox回归分析影响预后的因素。
脓毒症患者中男性76例,女性30例,平均年龄(68.1±14.7)岁。低Lac组51例患者中,有7例患有糖尿病。高Lac组55例患者中,有12例患有糖尿病。与低Lac组相比,高Lac组患者年龄更大、SOFA评分更高,病因控制治疗的患者比例更低(均P<0.05)。合并糖尿病和未合并糖尿病的脓毒症患者血Lac水平差异无统计学意义(mmol/L:3.03±2.73 vs. 2.81±2.40,P>0.05)。Kaplan-Meier生存曲线分析显示,高Lac组90天生存率显著低于低Lac组(56.36% vs. 90.20%,χ = 0.697,P = 0.008)。无糖尿病的高Lac组生存率更低,90天生存率显著低于无糖尿病的低Lac组(58.14% vs. 90.90%,χ = 7.152,P = 0.007);合并糖尿病的高Lac组与低Lac组90天生存率差异无统计学意义(50.00% vs. 85.71%,χ = 0.012,P = 0.914)。多因素Cox回归分析显示,血Lac是脓毒症患者预后的独立危险因素[比值比(OR)= 3.863,9置信区间(95%CI)= 1.237 - 12.060,P = 0.020]。根据糖尿病史分层后,血Lac是未合并糖尿病的脓毒症患者预后的独立危险因素(OR = 4.816,95%CI = 1.407 - 15.824,P = 0.010),但血Lac对合并糖尿病的脓毒症患者预后无影响(OR = 0.000,95%CI = 0.000 -